Is the Bitcoin crash finally over? A groundbreaking move by Chainlink and SWIFT may have just solved a $58 BILLION problem shaking global markets.
4 extracted signals · 4 resolved · 0 still active
Discover CryptoIndependent analyst profile- Source published
- 30 Sept 2025, 00:50 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The speaker provides a technical analysis of Bitcoin, Ethereum, Chainlink, Aerodrome and morpho finance. BTCUSD current is at 114367. The upside for BTCUSD is getting stronger. Potential rejection and an inverse head and shoulders pattern that may lead to wash people out. Watch at 118000 high. A look into the year is stair stepping up. There dips continue to truck, crushing potential of other future price. The overall thesis is long. Moving to LINKUSD it needs to break over 26$. The potential target of the golden pocket at 37$. ETHUSD Multi year trend line going back to 2021. Target Price up to 4837, and $AEROUSD has a bullish divergence as well on a smaller time frame and current price action sitting at 1.0593, the target 1.400, while Morpho finance upside target of is 2.600.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
4 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Discover Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.